CorVent Medical announced today that it received FDA 510(k) clearance for its Respond critical care ventilator system. The company designed Respond as a cost-effective option to deliver simple, safe and smart ventilation. It aims to expand access to quality care for healthcare systems, providers and patients. Respond, a lightweight, easy-to-use ventilator, combines elements of traditional […]
CorVent Medical
CorVent Medical appoints Jeremy Nelson as COO
CorVent Medical announced today that it appointed Jeremy Nelson as its new chief operating officer (COO). Fargo, North Dakota-based CorVent says Nelson brings nearly 20 years of operational experience to the role. His expertise comes across supply chain, manufacturing, engineering and automation. He will be based at CorVent’s Fargo office. “We are excited to add […]
CorVent Medical gains CE mark approval for critical care ventilator
CorVent Medical announced that it received CE mark approval for its Respond-19 ventilator and is preparing to launch it in Europe. Santa Clara, Calif.-based CorVent’s Respond-19 ventilator allows hospitals to treat more patients suffering from acute respiratory distress syndrome (ARDS). The system received FDA emergency use authorization (EUA) for primary critical care use in December […]
CorVent Medical wins EUA for multiple patient ventilator
CorVent Medical announced today that it received FDA emergency use authorization (EUA) for primary critical care use of its Respond-19 ventilator. Respond-19 is designed for the rapid expansion of critical care ventilation capacity by allowing hospitals to treat more patients suffering from acute respiratory distress syndrome (ARDS) amid the COVID-19 pandemic, according to a news […]
Startup CorVent Medical raises $4.5m for single-use ventilator
CorVent Medical today announced the closing of a $4.5 million seed financing round to support the commercialization of a single-use, critical care ventilator. The financing round is led by European life sciences venture capital firm Sofinnova Partners with participation from Redmile Group, Exor Seeds, Genesis Medtech Group, The Deerfield Foundation, The Pagliuca Family Office and […]
